Company Filing History:

11 out of 2,306

University of Minnesota

patents

1 out of 1,215

The United States of America As Represented by the Department of Health

patents

1 out of 28

The United States of America As Represented by the Secretary of Health

patents

4. 1 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2005

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6849712 - Peptides with β1 integrin subunit dependent cell adhesion modulating activity (2005-02-01),

2. 5840691 - Method for treating ischemia using polypeptides with fibronectin activity (1998-11-24),

3. 5731409 - Polypeptides with type I collagen activity (1998-03-24),

4. 5591719 - Method for treating acute and chronic inflammatory disorders using (1997-01-07),

5. 5545620 - Synthetic fibronectin fragments as inhibitors of retroviral infection (1996-08-13),

6. 5294551 - Cell culture substrate coated with polypeptides having fibronectin (1994-03-15),

7. 5171271 - Polypeptides with fibronectin activity (1992-12-15),

8. 5147797 - Polypeptides with fibronectin activity (1992-09-15),

9. 5116368 - Polypeptides with fibronectin activity (1992-05-26),

10. 5082926 - Polypeptide with type IV collagen cell adhesion, spreading and motility (1992-01-21),

11. 5019646 - Polypeptides with fibronectin activity (1991-05-28),

12. 4839464 - Polypeptides with fibronectin activity (1989-06-13),

Title: The Innovative Contributions of James B McCarthy

Introduction

James B McCarthy is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of biotechnology, particularly in the development of peptides and polypeptides with therapeutic applications. With a total of 12 patents, McCarthy's work has advanced our understanding of cell adhesion and ischemia treatment.

Latest Patents

Among his latest patents, McCarthy has developed peptides with β1 integrin subunit dependent cell adhesion modulating activity. These peptides, known as 'LipAr' C-terminated peptides, are designed to modulate the β1 integrin subunit dependent adhesion of cells, such as Ramos cells. Additionally, he has patented methods for treating ischemia using polypeptides with fibronectin activity. These methods involve administering polypeptides that correspond to specific amino acid sequences from fibronectin, which play a crucial role in cell adhesion.

Career Highlights

Throughout his career, McCarthy has worked with esteemed institutions, including the University of Minnesota and the United States Department of Health. His research has focused on the intersection of molecular biology and therapeutic applications, leading to innovative solutions in medical science.

Collaborations

McCarthy has collaborated with notable colleagues such as Leo T Furcht and Sharon M Wahl. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

James B McCarthy's innovative work in biotechnology has led to significant advancements in the understanding and treatment of various medical conditions. His contributions continue to impact the field and inspire future research.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.